Scientific Program









Live Stream from Berlin – in Tv Quality

Chat Window: Discuss with us! Send us your questions and comments!

Presidential Lecture I: What is the Role of Surgery in the Era of Targeted Therapies? Escalation or De-escalation?
Company Symposium (with the kind support of Daiichi Sankyo)
Presidential Lecture II: Which Therapies After CDK 4/6 Inhibitors?
Looking for Prognostic and Predictive Factors of Early Breast Cancer Patients – State of the Art and Upcoming Developments
Case of the Year – Never Seen Before (ICI +ADC)
Charité-Mayo Panel Discussion: What is the Charité Algorithm? What is the Best Approach, What is the Recommendation for Every Continent and What are the Recommendations for Regions With Limited Resources?

Presidential Lecture: What is the Role of Surgery in the Era of Targeted Therapies? Escalation or De-escalation?
Company Symposium
What is the Best Therapy for Advanced Ovarian Cancer? (HRD-positive/HRD-negative)
What is Now the Best Therapy in the Post-platinum Phase? (Let’s Break the Definition of Platinum Resistance)
Case of the Year – Never Seen Before
Charité-Mayo Panel Discussion: What is the Charité Algorithm? What is the Best Approach, What is the Recommendation for Every Continent and What are the Recommendations for Regions With Limited Resources?

Presidential Lecture: What is the Role of Surgery in the Era of Molecular Classification and the Era of Targeted Therapies? Escalation or De-escalation?
Company Symposium
What is the Best Therapy for Advanced Stages?
(MSI-high and Proficient)
What is the Best Therapy after Checkpoint Therapy?
Case of the Year – Never seen Before
Charité-Mayo Panel Discussion: What is the Charité Algorithm? What is the Best Approach, What is the Recommendation for Every Continent and What are the Recommendations for Regions With Limited Resources?
and more … (t.b.a.)

Presidential Lecture: What is the Role of Surgery in the Era of Targeted Therapies? Escalation or De-escalation?
Company Symposium
What is the Best Therapy in IB3-III (N0/N1)?
Surgery vs. Radiochemotherapy vs. Radioimmunotherapy vs. Induction Chemotherapy Plus Radiochemotherapy
Case of the Year – Never seen Before
Charité-Mayo Panel Discussion: What is the Charité Algorithm? What is the Best Approach, What is the Recommendation for Every Continent and What are the Recommendations for Regions With Limited Resources?
and more … (t.b.a.)

Status: December 2025; may be subject to change.